Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

PPARα agonists may help treat alopecia areata by reducing inflammation.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Skin has specialized touch receptors that can tell different sensations apart.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in certain receptors can cause diseases and offer new treatment options.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.